Co-founded by biomedical device designers, Resilient Medical Corp develops medical devices aimed at improving healing, led by its investigational Bravo™ implant for use during breast-cancer lumpectomies. Founded and led by biomedical engineer Andrew Weems, Ph.D., the company draws on decades of clinical experience and focuses on supporting breast tissue while providing a radiocontrast marker for post-operative therapy. Bravo is not currently for sale.